Loader

Pathways

PathWhiz ID Pathway Meta Data

PW127858

Pw127858 View Pathway
drug action

Levoleucovorin Action Pathway

Homo sapiens
Levoleucovorin is a folate analog, used to counter the adverse effects of folic acid antagonists. Commonly used in combination with chemotherapy and 5-fluorouracil to treat patients with colorectal cancer. Folic acid is necessary in order to produce purines, pyrimidines and methionine required for DNA synthesis and replication. Once transported into the mitochondria, levoleucovorin acts to inhibit serine hydroxymethyltransferase. Without this enzyme, this halts the DNA synthesis and replication process as 5,10-Methylene-THF cannot be made. 5,10 Methylene THF is an intermediate in many amino acid pathways, such as methionine synthesis. It is also used in thymidine synthesis which is a nucleoside needed for DNA replication.

PW146396

Pw146396 View Pathway
drug action

Levoleucovorin Drug Metabolism Action Pathway

Homo sapiens

PW146323

Pw146323 View Pathway
drug action

Levomefolic acid Drug Metabolism Action Pathway

Homo sapiens

PW132493

Pw132493 View Pathway
metabolic

Levomenol Drug Metabolism

Homo sapiens
Levomenol is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Levomenol passes through the liver and is then excreted from the body mainly through the kidney.

PW146592

Pw146592 View Pathway
drug action

Levomenol Drug Metabolism Action Pathway

Homo sapiens

PW000654

Pw000654 View Pathway
drug action

Levomethadyl Acetate Action Action Pathway

Homo sapiens
Levomethadyl acetate (also known as LAAM) is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, levomethadyl acetate is more active and more toxic than morphine. Levomethadyl acetate can bind to mu-type opioid receptor to activate associated G-protein in the sensory neurons of central nervous system (CNS), which will reduce the level of intracellular cAMP by inhibiting adenylate cyclase. The binding of levomethadyl acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter. Therefore, methadyl acetate can reduce nerve conduction and decrease neurotransmitter release; so that perception of pain signals can be blocked. Levomethadyl acetate can also open calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist) to reduce neuronal excitability as well as lead to hyperpolarization.

PW147017

Pw147017 View Pathway
metabolic

Levomethadyl Acetate Drug Metabolism Pathway

Homo sapiens

PW000614

Pw000614 View Pathway
drug metabolism

Levomethadyl Acetate Metabolism Pathway

Homo sapiens
Levomethadyl Acetate (also known as levacetylmethadol or levo-α-acetylmethadol) (LAAM), is a synthetic opioid structurally similar to methadone. It is an opioid agonist that has been used as an analgesic and to treat opioid dependence. Levomethadyl Acetate is metabolized by cytochrome P450 3A4 in two N-demethylation reactions to nor-levomethadyl acetate (nor-LAAM) and subsequently to dinor-levomethadyl acetate (dinor-LAAM).

PW132496

Pw132496 View Pathway
metabolic

Levomilnacipran Drug Metabolism

Homo sapiens
Levomilnacipran is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Levomilnacipran passes through the liver and is then excreted from the body mainly through the kidney.

PW145891

Pw145891 View Pathway
drug action

Levomilnacipran Drug Metabolism Action Pathway

Homo sapiens